Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BioElectronics Announces Western European Expansion
Marketwire
Posted: 2009-07-16 10:00:00
"We are already seeing strong successes in the Benelux, having recently begun selling BioElectronics' product in the region's largest online drugstore and we have strong interest among high-end drug store retailers," commented Gerard Lindhout, General Manager of Jumatro BV. "In addition to targeting both the professional and retail markets in conjunction with major European distributors, we are also developing a web environment called Gezondheidsstad (in English: Health City) to support online sales. I have used the ActiPatch product myself with great success and believe its drug-free approach to pain relief and healing is consistent with the needs of the European market. We look forward to working with BioElectronics to take these products across Western Europe and into Germany and Spain in particular."
Andrew Whelan, CEO of BioElectronics, added, "We selected a very strong partner to service Western Europe. Both Jumatro and Mr. Gerard have strong track records of success in the European markets. We look forward to supporting their European distribution expansion."
"We are already seeing strong successes in the Benelux, having recently begun selling BioElectronics' product in the region's largest online drugstore and we have strong interest among high-end drug store retailers," commented Gerard Lindhout, General Manager of Jumatro BV. "In addition to targeting both the professional and retail markets in conjunction with major European distributors, we are also developing a web environment called Gezondheidsstad (in English: Health City) to support online sales. I have used the ActiPatch product myself with great success and believe its drug-free approach to pain relief and healing is consistent with the needs of the European market. We look forward to working with BioElectronics to take these products across Western Europe and into Germany and Spain in particular."
Andrew Whelan, CEO of BioElectronics, added, "We selected a very strong partner to service Western Europe. Both Jumatro and Mr. Gerard have strong track records of success in the European markets. We look forward to supporting their European distribution expansion."
BioElectronics Announces Western European Expansion
Marketwire
Posted: 2009-07-16 10:00:00
Jumatro BV Partnering With One of the Largest Pharmacy Distributors in Europe
FREDERICK, MD -- (Marketwire) -- 07/16/09 -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced expansion into the Western European market via a strategic distribution agreement with Jumatro BV of the Netherlands. Jumatro is partnering with one of the largest pharmacy distributors in Europe to market the patented RecoveryRx(TM) brand of portable surgical recovery PEMF devices and is introducing the ActiPatch® Therapy brand into high-end and drug store retailers.
There are powerful forces messing with our heads trying to panic the herd to stampede. Nice way to pickup cheep. I will take advantage of cheep but I won’t sell cheep!!!
What’s really a scam is getting so many to panic in a sell off to pick up piles Cheap! And that what happened today! By end of day, it will be back up and by next week a lot of tears will flow.
BioCentric Energy, Warrior Girl Both Up on New Energy Sources
Warrior Girl Corp. (WRGL) and BioCentric Energy Holdings, Inc. (BEHL) were among this week's more exciting energy stocks. Warrior Girl's Pyrolitic Hydrocarbon Concentrator extracts oil from tar sands, while BioCentric's Photobioreactor turns algae into power.
San Diego, CA 7/10/2009 09:28 PM GMT (TransWorldNews)
BioCentric Energy Holdings, Inc. (BEHL) and Warrior Girl Corp. (WRGL) both unveiled novel energy-creation technologies this week, causing quite a stir with their respective stocks. To read the entire analytical review of this week's news, go to: www.smallcapnetwork.com/s/.
Barry Cohen viewed the first run of BioCentric's photobioreactor today, while Warrior Girl's Pyrolitic Hydrocarbon Concentrator unit - based on a unique and proprietary technology licensed from American Resource Energy Company (AREC) - can also be utilized to extract oil from other carbon based feedstock and oil shale.
You can ride the rollercoaster up and down trying to second guess every pump end dump or just strap yourself in for the rocket ride, because it’s coming and when the button gets pushed the stars will look like $$$$$$$$
push the button
Lock your trays Put your seats in an upright position!
15 min. to ride a rocket- just don’t know exactly they will push the button
Still those trying to S&B at the last min. –may miss the boat-
“Buy back in at .08, at the most” Your Dreaming!!
Selling now is lunacy
Up, Up and Away- anyone have a big red “S” to put on there chest?
SpongeTech® Delivery Systems, Inc. Reports New Orders in July of $6.9 Million to Date
Business Wire
Posted: 2009-07-09 12:45:00
SpongeTech® Delivery Systems, Inc., America’s Cleaning Company™, (OTCBB: SPNG) announced that the Company has secured approximately $6.9 million in new orders for the month of July to date. The successful marketing of SpongeTech®’s various products during the summer months are reflected by the continuous re-orders and new orders coming in from our retailers across the globe. SpongeTech®’s Car Care, Child Care, Home Care and Pet Care products can be purchased is various retail outlets including drugstores, supermarkets, membership warehouse clubs, and big box stores across the country and on the Company’s website at www.spongetech.com.
In addition to reporting new orders for the month of July, the Company will begin airing its new Uncle Norman’s™ Pet Sponge commercial on cable and satellite networks nationally next week. Due to the success of its DRTV marketing campaign on SpongeTech®’s Car Care product, the Company has produced a commercial for its Pet Care product line and expects to see the same success with the new commercial. Both commercials will continue to air nationally.
“This has been a great start to our first quarter and we believe we will continue to see strong growth within the Company moving forward,” comments SpongeTech®’s COO, Steven Moskowitz. "Our marketing campaign continues to support our retail distribution and we feel that our sell-through rates across our product lines will solidify revenue expectations through the current quarter.”
For more information, please contact Investor Relations at 1-877-SPONGE-T, and/or visit the Company's website at: www.spongetech.com
I just bought more SPNG –low thank you low dumpers- why do you jump out of a good stock? Look at the month’s av. It will be back at least to .17 likely in days
The BIOELECTRONICS-- PUMPERS and DUMPERS may dump themselves right out of position if they bale to low – I’m trying to selling my dead wood to buy more now!
This is hot!!
BioElectronics Prepares for General Surgical Recovery FDA 510(k) Premarketing Application Submission
10:00a ET July 9, 2009 (Market Wire)
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the Company is currently preparing an application for 510(k) premarket notification for submission to the Food and Drug Administration (FDA) for general surgical recovery. The filing will request an indication for the adjunct of use in palliative treatment of postoperative edema and pain in superficial soft tissue.
"There is overwhelming clinical data demonstrating the application of PEMF therapy significantly reduces postsurgical edema (swelling), pain and speeds healing. There are currently several devices cleared for this indication of use, but these devices are very large, expensive and are in no way portable, so they are neither practical nor marketable for surgical recovery. BioElectronics' portable version of PEMF, for which we recently were granted a patent, is very different. Our biomedical engineers have been able to shrink PEMF technology into a wearable patch that can be applied directly over the site of surgery," commented Andrew Whelan, CEO of BioElectronics. "Many surgeons are already using our products as an adjunctive therapy in the post-operative environment to speed healing and to significantly reduce, or in many cases, completely eliminate the use of narcotics, Tylenol(R) or acetaminophen, and NSAIDs to control surgical related pain within their patient populations."
BioElectronics Corp.'s RecoveryRX(TM) devices have already received FDA clearance for the treatment of edema following blepharoplasty, a common plastic surgery procedure. Gaining this additional FDA indication will allow the Company to market its products for use in the general surgical market, which consists of hundreds of thousands of procedures performed each year in both the ambulatory and outpatient environments. The Company recently filed with FDA for clearance to market its Allay(TM) Menstrual Pain Relief Patch product and is currently in process of completing numerous clinical trials designed to support additional marketing clearance applications with FDA.
BioElectronics Prepares for General Surgical Recovery FDA 510(k) Premarketing Application Submission
10:00a ET July 9, 2009 (Market Wire)
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the Company is currently preparing an application for 510(k) premarket notification for submission to the Food and Drug Administration (FDA) for general surgical recovery. The filing will request an indication for the adjunct of use in palliative treatment of postoperative edema and pain in superficial soft tissue.
"There is overwhelming clinical data demonstrating the application of PEMF therapy significantly reduces postsurgical edema (swelling), pain and speeds healing. There are currently several devices cleared for this indication of use, but these devices are very large, expensive and are in no way portable, so they are neither practical nor marketable for surgical recovery. BioElectronics' portable version of PEMF, for which we recently were granted a patent, is very different. Our biomedical engineers have been able to shrink PEMF technology into a wearable patch that can be applied directly over the site of surgery," commented Andrew Whelan, CEO of BioElectronics. "Many surgeons are already using our products as an adjunctive therapy in the post-operative environment to speed healing and to significantly reduce, or in many cases, completely eliminate the use of narcotics, Tylenol(R) or acetaminophen, and NSAIDs to control surgical related pain within their patient populations."
BioElectronics Corp.'s RecoveryRX(TM) devices have already received FDA clearance for the treatment of edema following blepharoplasty, a common plastic surgery procedure. Gaining this additional FDA indication will allow the Company to market its products for use in the general surgical market, which consists of hundreds of thousands of procedures performed each year in both the ambulatory and outpatient environments. The Company recently filed with FDA for clearance to market its Allay(TM) Menstrual Pain Relief Patch product and is currently in process of completing numerous clinical trials designed to support additional marketing clearance applications with FDA.
Warrior Girl isn’t going to NEED pumpers or DUMPER by the end of July – there on a serious track! It’s a hold – ride the bumps and hold on!!
Can someone say in simple terms what happening with SPNG-- going to go up, down?
Buy, sell @$? Or stay with it?
WHAT IS “Ihub”? HOW DO YOU GET IT?
financial statements, will by published by July 3, ?????????
Sorry, just getting the hang of how to post
What is EVFL going to open at Monday? Thoughts?
What is BIEL going to open at Monday? Thoughts?
Is SPNG a set-up w/the bottom about to fall through? Holding 2,237,225 Sh. @.01 a sale-off starting at .10 dn to .01 could make a pile of $
Fri. Trade SPNG sold for 2 min. @ .01 w/ 2,237,225 Sh. what’s up? Explain how-the middle of Fri. Trade SPNG sold for 2 min. @ .01 w/ 2,237,225 Sh. Traded w/ price from .07 to .10 before & after- what’s up